Results 31 to 40 of about 2,997,094 (204)

Factors associated with vulvar cancer from 2005 to 2021 in Togo, sub-Saharan Africa

BMC Women's Health, 2023
Background vulvar cancer, once predominantly diagnosed in older women, is increasingly being diagnosed in younger individuals, due to Human Papillomavirus (HPV) infection.
Tchin Darré, Bagassam Sama, Toukilnan Djiwa, Whitney E.D. Afantodji-Agbeti, Mayi Bombone, Yendoubé Kambote, Panakinao Simgban, Bingo K M’Bortche, Baguilane Douaguibe, Koffi Amégbor, Mazamaesso Tchaou, Abdoul-Samadou Aboubakari, Bayaki Saka, Gado Napo-Koura   +13 more
doaj   +1 more source

Vulvar neuroendocrine carcinoma that is independent of merkel cell polyomavirus and human papillomavirus suggests endometrial cancer recurrence: a case report

BMC Endocrine Disorders, 2022
Background Vulvar neuroendocrine carcinomas with small cell morphology need an appropriate differential diagnosis with respect to primary Merkel cell carcinomas, primary small cell neuroendocrine carcinomas, and secondary/metastatic carcinomas.
Tomoko Hirakawa, Mitsutake Yano, Haruto Nishida, Shimpei Sato, Kaei Nasu   +4 more
doaj   +1 more source

Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis. [PDF]

PLoS ONE, 2015
Time trends on the incidence and characteristics of invasive vulvar cancer in Germany have so far been studied in few local population- and hospital based tumor registries.
Nina Buttmann-Schweiger, Stefanie J Klug, Alexander Luyten, Bernd Holleczek, Florian Heitz, Andreas du Bois, Klaus Kraywinkel   +6 more
doaj   +1 more source

High-risk human papillomavirus-associated vulvar neoplasia among women living with human immunodeficiency virus in Zambia

African Journal of Laboratory Medicine, 2022
Background: Globally, women living with HIV have a higher risk of vulvar neoplasia than HIV-negative women. Vulvar neoplasia among women living with HIV has not previously been characterised in Zambia.
Fred Maate, Peter Julius, Stepfanie Siyumbwa, Leeya Pinder, Trevor Kaile, Mulindi Mwanahamuntu, Groesbeck Parham   +6 more
doaj   +1 more source

MRI in the Evaluation of Locally Advanced Vulvar Cancer Treated with Chemoradiotherapy and Vulvar Cancer Recurrence: The 2021 Revision of FIGO Classification and the Need for Multidisciplinary Management

, 2022
SIMPLE SUMMARY: Vulvar cancer is a rare gynecologic tumor (representing 4% of all gynecologic malignancies). We review the role of MRI in patients with locally advanced vulvar cancer (LAVC), highlighting the findings that influence clinical management ...
Russo, Luca, Manfredi, Riccardo, Scambia, Giovanni, Valentina Lancellotta, Gui, Benedetta, Luca Russo, Olivera Nicolic, Miriam Dolciami, Tagliaferri, Luca, Teresa Margarida Cunha, Maura Miccò, Lucia Manganaro, Giorgia Garganese, Nicolic, Olivera, Stefania Rizzo, Janicas, Catarina, Lancellotta, Valentina, Manganaro, Lucia, Riccardo Manfredi, Miccò, Maura, Persiani, Salvatore, Catarina Janicas, Cunha, Teresa Margarida, Giovanni Scambia, Salvatore Persiani, Garganese, Giorgia, Benedetta Gui, Rizzo, Stefania, Luca Tagliaferri, Dolciami, Miriam   +29 more
core   +1 more source

Biomimetic Scaffold‐Based 3D Models for Decoding Cancer Biology and Advancing Therapy

Advanced Science, EarlyView.
A timeline of the research history of 3D biomimetic scaffold materials and platforms. With advances in biomimetic materials and 3D scaffold technologies, their functional scope has expanded from mimicking basic physical and biochemical properties to increasingly replicating complex pathophysiological processes.
Haitao Zhao, Yuechen Han, Jie Li, Peng Luo, Lin Qi, Zhiwei Xia, Xiaosong Li, Quan Cheng, Chenshen Huang, Wantao Wu, Hao Zhang   +10 more
wiley   +1 more source

Prognostic Factors for Vulvar Cancer

Acta Clinica Croatica, 2021
The aim of this retrospective study was to show the effect of clinical, pathologic, cytologic and therapeutic prognostic factors on treatment outcome and survival of patients suffering from vulvar cancer and to determine prognostic significance of each
Ivana Miljanović-Špika, Maja Drežnjak Madunić, Zlatko Topolovec, Dajana Kujadin Kenjereš, Domagoj Vidosavljević   +4 more
doaj   +1 more source

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments—A VigiBase Disproportionality Analysis Study

Clinical Pharmacology &Therapeutics, EarlyView.
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian, Floriane Jochum, Elise Dumas, Florence Coussy, Kevin Bihan, Bénédicte Lebrun‐Vignes, Barbara Pistilli, Marc‐Antoine Benderra, Lise Selleret, Laurent Chouchana, Fabien Reyal, Anne‐Sophie Hamy, Paul Gougis   +12 more
wiley   +1 more source

The vulvar cancer risk in differentiated vulvar intraepithelial neoplasia: A systematic review

, 2021
Differentiated vulvar intraepithelial neoplasia (dVIN) is the precursor of human papil-lomavirus (HPV)-independent vulvar squamous cell carcinoma (VSCC). Given the rare incidence of dVIN, limited information on the exact cancer risk is available.
Voss, F. line O., Féline O. Voss, Maaike C. G. Bleeker, Thuijs, Nikki B., Vermeulen, Ravi F. M., Erica A. Wilthagen, Marc van Beurden, Bleeker, Maaike C. G., Nikki B. Thuijs, Wilthagen, Erica A., Ravi F. M. Vermeulen, van Beurden, Marc   +11 more
core   +1 more source

Long‐term quality of life, vulvar symptoms, and sexual functioning: A cross‐sectional study of Norwegian vulvar cancer survivors

Acta Obstetricia et Gynecologica Scandinavica
Introduction Vulvar cancer survivors are at risk of experiencing impaired health‐related quality of life and sexual functioning after treatment. However, studies on survivorship challenges, particularly several years after treatment, are scarce.
Christin Julia Meltzer‐Gunnes, Milada C. Hagen, Yun Wang, Pernille T. Jensen, Ingvild Vistad   +4 more
doaj   +1 more source